Effectiveness, safety, and biomarker dynamics of lecanemab in Chinese Alzheimer's disease population: a multicenter real-world study.

Liao W, Yu Q, Chen B, Chen H, Zou L, Xie H, Chen H, Wang C, Li Y, Gao X, Guo H, Yang Y, She Z, Zeng Q, Zhang Z, Li G, Feng S, Lin H, Ouyang J, Liang J, Ao W, Zeng Q, Liu Z, Weng H, Huang H, Zhu F, Liu R, Wang Y, Yu D, Li X, Mai Y, Jiang S, Tu Y, Li Z, Liu J, Alzheimer's Disease Neuroimaging Initiative

Open source

DOI: 10.1002/alz.71231
Published: 2026 Mar
Container: Alzheimer's & dementia : the journal of the Alzheimer's Association
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/alz.71231,
  title = {Effectiveness, safety, and biomarker dynamics of lecanemab in Chinese Alzheimer's disease population: a multicenter real-world study.},
  author = {Liao W and Yu Q and Chen B and Chen H and Zou L and Xie H and Chen H and Wang C and Li Y and Gao X and Guo H and Yang Y and She Z and Zeng Q and Zhang Z and Li G and Feng S and Lin H and Ouyang J and Liang J and Ao W and Zeng Q and Liu Z and Weng H and Huang H and Zhu F and Liu R and Wang Y and Yu D and Li X and Mai Y and Jiang S and Tu Y and Li Z and Liu J and Alzheimer's Disease Neuroimaging Initiative},
  year = {2026},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  doi = {10.1002/alz.71231},
  url = {https://doi.org/10.1002/alz.71231}
}

RIS

TY  - JOUR
TI  - Effectiveness, safety, and biomarker dynamics of lecanemab in Chinese Alzheimer's disease population: a multicenter real-world study.
AU  - Liao W
AU  - Yu Q
AU  - Chen B
AU  - Chen H
AU  - Zou L
AU  - Xie H
AU  - Chen H
AU  - Wang C
AU  - Li Y
AU  - Gao X
AU  - Guo H
AU  - Yang Y
AU  - She Z
AU  - Zeng Q
AU  - Zhang Z
AU  - Li G
AU  - Feng S
AU  - Lin H
AU  - Ouyang J
AU  - Liang J
AU  - Ao W
AU  - Zeng Q
AU  - Liu Z
AU  - Weng H
AU  - Huang H
AU  - Zhu F
AU  - Liu R
AU  - Wang Y
AU  - Yu D
AU  - Li X
AU  - Mai Y
AU  - Jiang S
AU  - Tu Y
AU  - Li Z
AU  - Liu J
AU  - Alzheimer's Disease Neuroimaging Initiative
PY  - 2026
JO  - Alzheimer's & dementia : the journal of the Alzheimer's Association
DO  - 10.1002/alz.71231
UR  - https://doi.org/10.1002/alz.71231
ER  -

APA

W, L., Q, Y., B, C., H, C., L, Z., H, X., H, C., C, W., Y, L., X, G., H, G., Y, Y., Z, S., Q, Z., Z, Z., G, L., S, F., H, L., J, O., J, L., W, A., Q, Z., Z, L., H, W., H, H., F, Z., R, L., Y, W., D, Y., X, L., Y, M., S, J., Y, T., Z, L., J, L., & Initiative, A. D. N. (2026). Effectiveness, safety, and biomarker dynamics of lecanemab in Chinese Alzheimer's disease population: a multicenter real-world study.. Alzheimer's & dementia : the journal of the Alzheimer's Association. https://doi.org/10.1002/alz.71231

Source records

pubmed · retrieved 2026-09-26T11:19:54.796Z